Article Information
PubMed
Published By
History
- Received September 20, 2018
- Revision received January 18, 2019
- Accepted January 26, 2019
- Published online February 19, 2019.
Copyright & Usage
Copyright © 2019 Asaoka et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Nozomi Asaoka1,
- Naoya Nishitani1,
- Haruko Kinoshita1,
- Yuma Nagai1,
- Hikari Hatakama1,
- Kazuki Nagayasu1,
- Hisashi Shirakawa1,
- Takayuki Nakagawa2 and
- Shuji Kaneko1
- 1Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan
- 2Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto 606-8507, Japan
- Correspondence should be addressed to Kazuki Nagayasu at nagayasu{at}pharm.kyoto-u.ac.jp or Shuji Kaneko at skaneko{at}pharm.kyoto-u.ac.jp.
Author contributions
Author contributions: N.A., K.N., H.S., T.N., and S.K. designed research; N.A., H.K., and H.H. performed research; N.A., N.N., H.K., Y.N., and H.H. analyzed data; N.A., K.N., and S.K. wrote the paper; N.N. and Y.N. contributed unpublished reagents/analytic tools.
Disclosures
The authors declare no competing financial interests.
This work was supported by the Japanese Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (KAKENHI) 16H05091 (to K.N., H.S., T.N., and S.K.) and the Japan Agency for Medical Research and Development (AMED) Grant 18ak0101088h0001 (to S.K.).
Funding
Japanese Society for the Promotion of Science (JSPS)
16H05091Japan Agency for Medical Research and Development (AMED)
18ak0101088h0001
Other Version
- previous version (February 19, 2019).
- You are viewing the most recent version of this article.
Statistics from Altmetric.com
Article usage
In this issue
An Adenosine A2A Receptor Antagonist Improves Multiple Symptoms of Repeated Quinpirole-Induced Psychosis
